Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Test exchanges : Nasdaq save search
MICRO-ANT PASSES KEY TEST MILESTONE FOR IRIDIUM CERTUS AIRBORNE ANTENNA
Published: 2024-04-22 (Crawled : 19:00) - prnewswire.com
IRDM | News | $28.99 -0.99% 100K
|
Communications
|
| O: -0.92%
H: 3.41%
C: 3.2%
certus test for key iridium milestone
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Published: 2024-04-22 (Crawled : 17:00) - biospace.com/
VCYT | News | $19.26 -3.22% 52K
|
Health Technology
|
| O: 1.03%
H: 2.65%
C: 1.02%
active test cancer for study
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
GH | News 4 | $17.38 -3.98% 72K
|
Health Services
|
| O: 4.42%
H: 5.36%
C: 4.83%
fda test review cancer blood for
Innoviz Reaches a Key Milestone with Successful Winter Test of InnovizTwo LiDAR and AI-Powered Perception Software, Showcasing Significant Progress and New Opportunities
Published: 2024-04-18 (Crawled : 13:00) - prnewswire.com
INVZ | $0.9846 -2.51% 110K
|
|
| O: 0.93%
H: 0.0%
C: 0.0%
test key milestone lidar
Kratos Defense & Security Solutions, Inc. Completes Development of the Zeus Solid Rocket Motor (SRM) Family with the Successful Zeus 2 Static Test Fire
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
KTOS 4 | $17.355 -2.34% 76K
|
Electronic Technology
|
| O: 0.33%
H: 0.82%
C: -2.9%
defense test security family
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
DARE | $0.286 44K
|
Health Technology
|
| O: 1.36%
H: 0.68%
C: -0.64%
ovaprene test positive bioscience publication contraceptive contraception study
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
QDEL | News 4 | $39.35 -3.6% 71K
|
Health Technology
|
| O: -2.64%
H: 2.3%
C: 1.24%
vitros partnership test assay
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
PRPH | $5.06 2K
|
Health Technology
|
| O: -7.22%
H: 2.98%
C: 1.49%
management test cancer
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
EXAS | $60.04 -5.06% 510K
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
test sciences meeting study
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA | News M | $88.14 -3.67% 110K
|
Health Services
|
| O: 0.92%
H: 0.26%
C: -2.26%
test for heart
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
EXAS | $60.04 -5.06% 510K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
oncoguard test cancer sciences
VIAVI Demonstrates Leadership in RAN Intelligence Test and Training at 2024 RIC Forum
Published: 2024-03-28 (Crawled : 11:00) - prnewswire.com
VIAV | $7.925 -0.81% 80K
|
Electronic Technology
|
| O: -0.1%
H: 0.31%
C: -5.02%
test intelligence
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
Published: 2024-03-26 (Crawled : 17:00) - biospace.com/
PSNL | $1.215 -6.54% 64K
|
Health Technology
|
| O: 4.17%
H: 2.0%
C: -4.67%
personal test cancer publication treatment response
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
Published: 2024-03-25 (Crawled : 20:00) - globenewswire.com
QGEN | $40.76 -1.83% 310K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
QGEN | $40.76 -1.83% 310K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
test system collaboration results
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
GENE | News 0 d | $2.25 1.3K
|
Health Technology
|
| O: 1.12%
H: 1.85%
C: -5.19%
test risk advanced
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
Published: 2024-03-22 (Crawled : 11:00) - prnewswire.com
TECH | $62.24 -2.02% 83K
|
Health Technology
|
| O: 0.07%
H: 0.1%
C: -1.22%
certification test diagnostic leukemia
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
ILMN | $118.565 -3.5% 82K
|
Health Technology
|
| O: 0.51%
H: 2.49%
C: 1.37%
AZN | News | $75.37 5.86% 2.7M
|
Health Technology
|
| O: -0.45%
H: 0.55%
C: -0.24%
lung test cancer risk study
EchoStar Completes Nationwide Drive Test for Boost Wireless Network, Completing All 2023 FCC Commitments
Published: 2024-03-14 (Crawled : 15:30) - prnewswire.com
SATS | $15.71 -1.07% 160K
|
Electronic Technology
|
| O: -0.97%
H: 0.59%
C: -7.71%
test nationwide
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
GH | News 4 | $17.38 -3.98% 72K
|
Health Services
|
| O: -0.75%
H: 4.38%
C: 2.7%
test health cancer study
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
EXAS | $60.04 -5.06% 510K
|
Health Technology
|
| O: -0.43%
H: 1.9%
C: 1.06%
cologuard test results study
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
ACON | $0.49 70.14% 24M
|
n/a
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.13 56.5% 500K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.